News
Oncopeptides has completed a directed share issue of SEK 314 million
Published
22.3.18
Oncopeptides today announces that the company has successfully completed a directed share issue of approximately SEK 314 million (USD 38 million).
WE'RE SWEDEN'S
Venture capital fund
Industrifonden
Vasagatan 11
PO Box 1163
111 91 Stockholm
Sweden
Get directions
Phone: +46 8 587 919 00
E-mail: info@industrifonden.com
ⓒ 2026 Industrifonden